Integrated Annual Reports

Overview

The report presents Torrent Pharma's FY 2024-25 performance through an integrated view of consolidated growth and sustainability. Revenue reached ₹11,516 crores, while the company reported a 41.5% renewable energy share, a 32.4% reduction in Scope 1 and 2 carbon footprint from the 2019-20 base year, and zero fatalities. It also expanded Scope 3 reporting to ten categories, alongside water recycling, waste recovery and broad employee and community programmes. Governance highlights include Board oversight of ESG integration and independent assurance by Grant Thornton Bharat LLP.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2024-2025
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services